Form 8-K - Current report:
SEC Accession No. 0000950170-23-035497
Filing Date
2023-07-28
Accepted
2023-07-28 16:12:06
Documents
12
Period of Report
2023-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20230726.htm   iXBRL 8-K 88963
  Complete submission text file 0000950170-23-035497.txt   215992

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20230726.xsd EX-101.SCH 2459
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20230726_lab.xml EX-101.LAB 13895
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20230726_pre.xml EX-101.PRE 11427
6 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20230726_htm.xml XML 4870
Mailing Address 4 CORPORATE DRIVE ANDOVER MA 01810
Business Address 4 CORPORATE DRIVE ANDOVER MA 01810 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

EIN.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 231123156
SIC: 2834 Pharmaceutical Preparations